✦ LIBER ✦

Pulpal anesthesia dependent on epinephrine dose in 2% lidocaine: A randomized controlled double-blind crossover study

✍ Scribed by Elisabeth Knoll-Köhler; Gabriele Förtsch

Book ID: 113198747
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 498 KB
Volume: 73
Category: Article
ISSN: 0030-4220
DOI: 10.1016/0030-4220(92)90091-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analgesic Effect of Intravenous Ketamine

Analgesic Effect of Intravenous Ketamine in Cancer Patients on Morphine Therapy: A Randomized, Controlled, Double-Blind, Crossover, Double-Dose Study

✍ Sebastiano Mercadante; Edoardo Arcuri; Walter Tirelli; Alessandra Casuccio 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Dose-dependent effects of anapsos in sen

Dose-dependent effects of anapsos in senile dementia patients: A double-blind, randomized, placebo controlled study

✍ Anton Alvarez; Victor Pichel; Paula Perez; Marta Laredo; Lola Corzo; Raquel Zas; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Randomized, double-blind, placebo-contro

Randomized, double-blind, placebo-controlled study of ALGRX 3268: A topical lidocaine delivery system for topical anesthesia prior to venipuncture in children

✍ W. Zempsky; E. Vause; D. Sykes; B. Robbins; L. Benson; M. Hoffman; P. Richards; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Subcutaneous apomorphine in patients wit

Subcutaneous apomorphine in patients with advanced Parkinson's disease: A dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single dose

✍ Rajesh Pahwa; William C. Koller; Richard M. Trosch; James H. Sherry 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 471 KB

Fontolizumab in moderate to severe Crohn

Fontolizumab in moderate to severe Crohn's disease: A phase 2, randomized, double-blind, placebo-controlled, multiple-dose study

✍ Walter Reinisch; Williem de Villiers; László Bene; László Simon; István Rácz; Se 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB

## Background: The safety and efficacy of fontolizumab, a humanized anti-interferon gamma antibody, was investigated in patients with Crohn's disease (CD). Elevated gut mucosal levels of interferon gamma, a key cytokine involved in the inflammatory process of CD, are associated with disease symptom

Dose-dependent Safety and Efficacy of Zo

Dose-dependent Safety and Efficacy of Zonisamide: A Randomized, Double-blind, Placebo-controlled Study in Patients with Refractory Partial Seizures

✍ Martin J. Brodie; Roderick Duncan; Herve Vespignani; Andras Solyom; Valeriy Bite 📂 Article 📅 2005 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 170 KB